Author:
Alfuraih Abdulrahman,Alzimami Khalid,Ma Andy K.,Alghamdi Ali,Al Jammaz Ibrahim
Reference17 articles.
1. Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET;Aerts;J. Nucl. Med.,2009
2. Optimization of 89Zr production using Monte Carlo simulations;Alfuraih;J. Radioanal. Nucl. Chem.,2012
3. Avila-Rodriguez, M.A., Selwyn, R.G., Converse, A.K., Nickles, R.J., 2006. 86Y and 89Zr as PET imaging surrogates for 90Y: a comparative study, In: Proceedings of the Ninth Mexican Symposium on Medical Physics. pp. 45–47.
4. Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients;Börjesson;J. Nucl. Med.,2009
5. Production and purification of 89Zr, a potential PET antibody label;Dejesus;Int. J. Radiat. Appl. Instrum. A,1990
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献